₹225
(Inclusive of all Taxes)
₹33.8 Cashback (15%)
Prescription drugWhats That
Drug-Drug Interactions
Severe
ClindamycinBacitracin
Severe
Drug-Drug Interactions
Login/Sign Up
Severe
How does the drug interact with Clindacef 300mg Capsule:
Co-administration of Clindacef 300mg Capsule with Balsalazide may reduce the effectiveness of Balsalazide.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with balsalazide if prescribed by the doctor. Consult the prescriber if you have any concerns, the doctor may prescribe alternatives that do not interact, dose adjustment, or more frequent monitoring to safely use both medications. Do not discontinue the medication without consulting a doctor.
Co-administration of Clindacef 300mg Capsule with Balsalazide may reduce the effectiveness of Balsalazide.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with balsalazide if prescribed by the doctor. Consult the prescriber if you have any concerns, the doctor may prescribe alternatives that do not interact, dose adjustment, or more frequent monitoring to safely use both medications. Do not discontinue the medication without consulting a doctor.
ClindamycinBacitracin
Severe
How does the drug interact with Clindacef 300mg Capsule:
Co-administration of Clindacef 300mg Capsule with Bacitracin may increase the risk of kidney and/or nerve damage.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with bacitracin if prescribed by the doctor. Consult the prescriber if you experience signs and symptoms of kidney damage such as sudden weight gain or weight loss, nausea, vomiting, fluid retention, loss of appetite, increased or decreased urination, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Let your doctor know if you develop seizures; hearing problems; or numbness, burning or tingling in your hands and feet. If you develop diarrhoea or vomiting during treatment with these medications, drink plenty of fluids to prevent dehydration, as dehydration may harm the kidney.
Co-administration of Clindacef 300mg Capsule with Bacitracin may increase the risk of kidney and/or nerve damage.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with bacitracin if prescribed by the doctor. Consult the prescriber if you experience signs and symptoms of kidney damage such as sudden weight gain or weight loss, nausea, vomiting, fluid retention, loss of appetite, increased or decreased urination, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Let your doctor know if you develop seizures; hearing problems; or numbness, burning or tingling in your hands and feet. If you develop diarrhoea or vomiting during treatment with these medications, drink plenty of fluids to prevent dehydration, as dehydration may harm the kidney.
Severe
How does the drug interact with Clindacef 300mg Capsule:
Concomitant use of Clindacef 300mg Capsule with ceritinib can increase the effects of Clindacef 300mg Capsule
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with ceritinib if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain, or diarrhoea.
Concomitant use of Clindacef 300mg Capsule with ceritinib can increase the effects of Clindacef 300mg Capsule
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with ceritinib if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain, or diarrhoea.
Severe
How does the drug interact with Clindacef 300mg Capsule:
Co-administration of Clindacef 300mg Capsule with Atracurium can increase the risk of muscle weakness.
How to manage the interaction:
Taking Clindacef 300mg Capsule with Atracurium together can possibly result in an interaction, but it can be taken if a doctor has advised it. "Clindacef 300mg Capsule can affect the muscles and nerves in your body. When used with other medications that also affect the muscles and nerves, it can cause a serious problem called neuromuscular blockade. If you have trouble breathing or can't breathe at all, please call your doctor right away." Do not stop using any medications without a doctor's advice.
Co-administration of Clindacef 300mg Capsule with Atracurium can increase the risk of muscle weakness.
How to manage the interaction:
Taking Clindacef 300mg Capsule with Atracurium together can possibly result in an interaction, but it can be taken if a doctor has advised it. "Clindacef 300mg Capsule can affect the muscles and nerves in your body. When used with other medications that also affect the muscles and nerves, it can cause a serious problem called neuromuscular blockade. If you have trouble breathing or can't breathe at all, please call your doctor right away." Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Clindacef 300mg Capsule:
Co-administration of of Clindacef 300mg Capsule with gentamicin may increase the risk of kidney and/or nerve damage.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with gentamicin if prescribed by the doctor. Consult the prescriber if you experience signs and symptoms of kidney damage such as sudden weight gain or weight loss, nausea, vomiting, fluid retention, loss of appetite, increased or decreased urination, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. If you develop diarrhea or vomiting during treatment with these medications, drink plenty of fluids to prevent dehydration, as dehydration may also harm the kidney.
Co-administration of of Clindacef 300mg Capsule with gentamicin may increase the risk of kidney and/or nerve damage.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with gentamicin if prescribed by the doctor. Consult the prescriber if you experience signs and symptoms of kidney damage such as sudden weight gain or weight loss, nausea, vomiting, fluid retention, loss of appetite, increased or decreased urination, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. If you develop diarrhea or vomiting during treatment with these medications, drink plenty of fluids to prevent dehydration, as dehydration may also harm the kidney.
ClindamycinFosphenytoin
Severe
How does the drug interact with Clindacef 300mg Capsule:
When Clindacef 300mg Capsule is taken with Fosphenytoin, it can cause the body to process Clindacef 300mg Capsule faster.
How to manage the interaction:
Although there is a possible interaction between Clindacef 300mg Capsule and Fosphenytoin, you can take these medicines together if prescribed by your doctor. If you notice any symptoms like sudden drowsiness, fatigue, confusion, itching, burning, or tingling sensation, abnormal body movements, or loss of coordination, make sure to contact your doctor right away. Do not stop using any medications without first talking to your doctor.
When Clindacef 300mg Capsule is taken with Fosphenytoin, it can cause the body to process Clindacef 300mg Capsule faster.
How to manage the interaction:
Although there is a possible interaction between Clindacef 300mg Capsule and Fosphenytoin, you can take these medicines together if prescribed by your doctor. If you notice any symptoms like sudden drowsiness, fatigue, confusion, itching, burning, or tingling sensation, abnormal body movements, or loss of coordination, make sure to contact your doctor right away. Do not stop using any medications without first talking to your doctor.
How does the drug interact with Clindacef 300mg Capsule:
When Ethinylestradiol and Clindacef 300mg Capsule are taken together, the effects of Clindacef 300mg Capsule can be reduced.
How to manage the interaction:
There may be a possibility of interaction between Ethinylestradiol and Clindacef 300mg Capsule, but it can be taken if prescribed by a doctor. Do not stop using any medications without a doctor's advice.
When Ethinylestradiol and Clindacef 300mg Capsule are taken together, the effects of Clindacef 300mg Capsule can be reduced.
How to manage the interaction:
There may be a possibility of interaction between Ethinylestradiol and Clindacef 300mg Capsule, but it can be taken if prescribed by a doctor. Do not stop using any medications without a doctor's advice.
How does the drug interact with Clindacef 300mg Capsule:
Taking Clindacef 300mg Capsule with clarithromycin may increase the effects of Clindacef 300mg Capsule.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with clarithromycin if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain, or diarrhea. Do not discontinue the medication without consulting a doctor.
Taking Clindacef 300mg Capsule with clarithromycin may increase the effects of Clindacef 300mg Capsule.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with clarithromycin if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain, or diarrhea. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Clindacef 300mg Capsule:
Co-administration of Clindacef 300mg Capsule with Atazanavir may increase the effects of Clindacef 300mg Capsule.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with atazanavir if prescribed by the doctor. Consult the prescriber if you experience persistent nausea, vomiting, diarrhea, or abdominal pain. Do not discontinue the medication without consulting a doctor.
Co-administration of Clindacef 300mg Capsule with Atazanavir may increase the effects of Clindacef 300mg Capsule.
How to manage the interaction:
Although there is a possible interaction, Clindacef 300mg Capsule can be taken with atazanavir if prescribed by the doctor. Consult the prescriber if you experience persistent nausea, vomiting, diarrhea, or abdominal pain. Do not discontinue the medication without consulting a doctor.
How does the drug interact with Clindacef 300mg Capsule:
Taking Clindacef 300mg Capsule with Botulinum toxin can increase the risk or severity of side effects.
How to manage the interaction:
Taking Clindacef 300mg Capsule with Botulinum toxin together can result in an interaction, they can be taken together if prescribed by a doctor. However, if you experience any unusual symptoms contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Clindacef 300mg Capsule with Botulinum toxin can increase the risk or severity of side effects.
How to manage the interaction:
Taking Clindacef 300mg Capsule with Botulinum toxin together can result in an interaction, they can be taken together if prescribed by a doctor. However, if you experience any unusual symptoms contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
Author Details
Drug-Diseases Interactions
CLINDAMYCIN-300MGOther bacterial intestinal infections
Severe
CLINDAMYCIN-300MGDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
Drug-Diseases Interactions
Login/Sign Up
CLINDAMYCIN-300MGOther bacterial intestinal infections
Severe
How does the disease interact with Clindacef 300mg Capsule:
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
CLINDAMYCIN-300MGDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
How does the disease interact with Clindacef 300mg Capsule:
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
CLINDAMYCIN-300MGOther diseases of liver
Moderate
How does the disease interact with Clindacef 300mg Capsule:
The liver is the primary site of Clindacef 300mg Capsule metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Clindacef 300mg Capsule and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Clindacef 300mg Capsule therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Clindacef 300mg Capsule is primarily metabolized by the liver. Therapy with Clindacef 300mg Capsule should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
The liver is the primary site of Clindacef 300mg Capsule metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Clindacef 300mg Capsule and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Clindacef 300mg Capsule therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Clindacef 300mg Capsule is primarily metabolized by the liver. Therapy with Clindacef 300mg Capsule should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
CLINDAMYCIN-300MGOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Clindacef 300mg Capsule:
Clindacef 300mg Capsule is partially removed by the kidney. Clindacef 300mg Capsule should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindacef 300mg Capsule concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindacef 300mg Capsule should be administered cautiously in patients with severely impaired renal function. Serum Clindacef 300mg Capsule concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Clindacef 300mg Capsule is partially removed by the kidney. Clindacef 300mg Capsule should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindacef 300mg Capsule concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindacef 300mg Capsule should be administered cautiously in patients with severely impaired renal function. Serum Clindacef 300mg Capsule concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
CLINDAMYCIN-300MGOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Clindacef 300mg Capsule:
Clindacef 300mg Capsule is partially removed by the kidney. Clindacef 300mg Capsule should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindacef 300mg Capsule concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindacef 300mg Capsule should be administered cautiously in patients with severely impaired renal function. Serum Clindacef 300mg Capsule concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Clindacef 300mg Capsule is partially removed by the kidney. Clindacef 300mg Capsule should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindacef 300mg Capsule concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Clindacef 300mg Capsule should be administered cautiously in patients with severely impaired renal function. Serum Clindacef 300mg Capsule concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Have a query?
